MedPath

Transcriptome analysis of circulating monocytes from patients with stable plaques and patients with unstable plaques.

Completed
Conditions
Cardiovascular disease
Hardening or furring of the arteries
10003216
10011082
Registration Number
NL-OMON29831
Lead Sponsor
Academisch Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
779
Inclusion Criteria

Unstable angina (IIA, IIIA, IIB, IIIB-Tneg): Clinical symptoms secondary to recent coronary plaque rupture, history of recent unstable angina, ECG repolarization abnormalities, statin treatment (> 2 months).
Stable angina patients: Stable atherosclerotic lesion(s) identified during coronary angiography, treated for more than 2 months for angina pectoris,
statin treatment (> 2 months).
Rheumatoid arthritis patients: Diagnosed as having Rheumatoid Arthritis for longer than 12 months, statin treatment (> 2 months).

Exclusion Criteria

Unstable angina (IIA, IIIA, IIB, IIIB-Tneg): Recent history of acute myocardial infarction (in the past year), elevated troponin-T levels, diabetic, smoker, under 18 yrs of age, clinical manifestation of extracardiac atherosclerotic disease.
Stable angina patients: Recent history of unstable angina or Acute Myocardial Infarction, diabetic, smoker, under 18 yrs of age, clinical manifestation of extracardiac atherosclerotic disease.
Rheumatoid arthritis: Clinical symptoms of atherslerotic disease, diabetic, smoker, under 18 yrs of age.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Relative gene expression levels in monocytes from different inflammatory<br /><br>disease patient groups.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>A questionaire concerning the habits and the disease progression of the<br /><br>patients will be conducted. This will be used in later correlation studies. A<br /><br>folow-up questionaire will be taken after 12 months</p><br>
© Copyright 2025. All Rights Reserved by MedPath